| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Shuvra Ray | |
| Theresa T Pizarro | |||
| Carlo De Salvo | |||
| P2860 | cites work | Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease | Q24601772 |
| Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease | Q24646902 | ||
| Increased expression of interleukin 17 in inflammatory bowel disease | Q29622829 | ||
| Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease | Q30307038 | ||
| Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis | Q30310728 | ||
| Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease | Q30311921 | ||
| SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis | Q30423660 | ||
| Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation | Q30436253 | ||
| Role of TL1A and its receptor DR3 in two models of chronic murine ileitis | Q30440458 | ||
| Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis | Q30442649 | ||
| Interactions between the host innate immune system and microbes in inflammatory bowel disease | Q33554402 | ||
| The microbiome in inflammatory bowel disease: current status and the future ahead | Q33664898 | ||
| Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent | Q33730117 | ||
| Airway remodeling in asthma | Q33753444 | ||
| Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis | Q33802845 | ||
| Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2-/- (TRUC) mice. | Q33835084 | ||
| Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells | Q34150690 | ||
| Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial | Q34275637 | ||
| Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation | Q34327935 | ||
| Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease | Q34459129 | ||
| IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 | Q34521302 | ||
| IL-13 promotes collagen accumulation in Crohn's disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells? | Q34540573 | ||
| Angiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection | Q34706971 | ||
| Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease. | Q35611798 | ||
| Medical therapy for Crohn's disease strictures | Q35731494 | ||
| Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats | Q35744613 | ||
| Immunosuppressive treatment protects against angiotensin II-induced renal damage | Q35747734 | ||
| Fibrotic disease and the T(H)1/T(H)2 paradigm | Q35852270 | ||
| Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1. | Q35920106 | ||
| Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis | Q35951975 | ||
| The use of angiotensin receptor blockers in the treatment of chronic heart failure | Q35954136 | ||
| Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study | Q36503291 | ||
| TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease | Q36639973 | ||
| SUSTAINED TL1A (TNFSF15) EXPRESSION ON BOTH LYMPHOID AND MYELOID CELLS LEADS TO MILD SPONTANEOUS INTESTINAL INFLAMMATION AND FIBROSIS. | Q36800644 | ||
| TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. | Q37019308 | ||
| The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis | Q37070931 | ||
| Dysregulated NOD2 predisposes SAMP1/YitFc mice to chronic intestinal inflammation | Q37240497 | ||
| A protective function for interleukin 17A in T cell-mediated intestinal inflammation | Q37260173 | ||
| Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. | Q37329670 | ||
| Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease | Q37419668 | ||
| Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. | Q37483138 | ||
| Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. | Q37610002 | ||
| Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies | Q38013891 | ||
| Mechanisms and models for intestinal fibrosis in IBD. | Q38296801 | ||
| Potential roles of interleukin-17A in the development of skin fibrosis in mice | Q39308063 | ||
| Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice | Q39333394 | ||
| IL-23/IL-17 immunity as a hallmark of Crohn's disease | Q39977129 | ||
| Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats | Q40673218 | ||
| Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). | Q42101278 | ||
| Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model | Q42126346 | ||
| Cellular and molecular mechanisms of intestinal fibrosis | Q42252132 | ||
| Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's disease. | Q43145801 | ||
| IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation | Q43513541 | ||
| Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension | Q44225009 | ||
| Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease. | Q44628467 | ||
| Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts | Q44671853 | ||
| Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study | Q44755697 | ||
| Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study | Q45042350 | ||
| Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis | Q45286196 | ||
| Secukinumab failure in Crohn's disease: the yeast connection? | Q45370364 | ||
| Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial | Q46911236 | ||
| IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway. | Q50512444 | ||
| Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. | Q54765190 | ||
| Activation and suppression of renin–angiotensin system in human dendritic cells | Q57362707 | ||
| Angiotensin II induces contraction and proliferation of human hepatic stellate cells | Q61576239 | ||
| Role of oxygen-derived free radicals in acute angiotensin II--induced hypertensive vascular disease in the rat | Q68715371 | ||
| Immunohistochemical localization of angiotensin II receptor and local renin-angiotensin system in human colonic mucosa | Q77513348 | ||
| TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort | Q83252105 | ||
| Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study | Q86014195 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 531-538 | |
| P577 | publication date | 2014-11-01 | |
| P1433 | published in | Current Opinion in Gastroenterology | Q15758708 |
| P1476 | title | Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis | |
| P478 | volume | 30 |
| Q90193726 | Autophagy Stimulation as a Potential Strategy Against Intestinal Fibrosis |
| Q40288354 | CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer |
| Q27027429 | Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease |
| Q89986846 | Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis |
| Q89425548 | Effect of Homocysteine on the Differentiation of CD4+ T Cells into Th17 Cells |
| Q38695350 | Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy |
| Q55190074 | Heat shock protein 70 protects mouse against post-infection irritable bowel syndrome via up-regulating intestinal γδ T cell's Th17 response. |
| Q39182623 | IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats |
| Q53222506 | IL-17-driven intestinal fibrosis is inhibited by Itch-mediated ubiquitination of HIC-5. |
| Q42369863 | Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis. |
| Q58541796 | Interleukin-17A and B-cell activating factor in chronic hepatitis C patients with or without asymptomatic mixed cryoglobulinemia: effects of antiviral treatment and correlations with vitamin D |
| Q26770666 | Osteoimmune Interactions in Inflammatory Bowel Disease: Central Role of Bone Marrow Th17 TNFα Cells in Osteoclastogenesis |
| Q93075393 | Pathogenesis of fibrostenosing Crohn's disease |
| Q36373253 | Reversibility of Stricturing Crohn's Disease-Fact or Fiction? |
| Q38853672 | The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease |
Search more.